Daniel Stover, MD
College of Medicine
Daniel Stover, MD is a breast medical oncologist and translational physician-scientist and member of the Translational Therapeutics Program at OSUCCC – James. Dr. Stover’s research focus is resistance to therapy in breast cancer through genomic and computational analyses of patient samples.
The Stover Lab research focus is clinical computational oncology – the application of computational approaches to leverage the immense available and potential data from tumor genomic profiling to improve outcomes for patients with cancer. By studying patient samples, including on clinical trials, the lab seeks to identify new mechanisms of drug resistance to standard agents as well as investigational agents. The ultimate goal of this work is to identify predictive markers for treatment response while identifying novel susceptibilities that allow us to overcome drug resistance.
Specific research areas include:
- Application of novel genomic technologies in patient and clinical trial samples.
- Answering emerging clinical questions by interrogating existing ‘omic datasets.
- Evolutionary profiling of tumors over time and in response to therapy.
- Association of environmental exposures with tumor and microenvironmental features.
Dr. Stover has co-authored over 20 scientific manuscripts in journals including Cell, Nature, Nature Medicine, and Clinical Cancer Research, among others.